The Y522S mutation in RyR1 alters SR Ca2+ buffering and permeability in skeletal muscle, mimicking reduced calsequestrin and reduced Ca2+-dependent inactivation, which may precipitate malignant hyperthermia.
These Ca2+ dynamics in YS cells may underlie MH susceptibility; leaves open human translation and targeted interventions.
Key points Malignant Hyperthermia (MH) affects the Ca 2+ movements that control muscle contraction. We measured Ca 2+ movements in skeletal muscle of “Y522S” mice, with a tyrosine‐to‐serine mutation in the RyR channel that causes MH in mice and humans. In YS cells, [Ca 2+ ] inside the Ca 2+ store (sarcoplasmic reticulum, SR) was 45% of that in the wild type (WT), but the SR membrane permeability increased 2‐fold, resulting in Ca 2+ release of initially normal value. During Ca 2+ release, cytosolic [Ca 2+ ] and SR Ca 2+ buffering power evolved differently in YS and WT. These variables became similar in WT exposed to BAPTA, an inhibitor of Ca 2+ ‐dependent inactivation (CDI) of the RyR, suggesting that tyrosine 522 is involved in CDI. Similar paradoxical observations in YS and WT cells with reduced content of the SR protein calsequestrin, revealed the importance of balance between SR Ca permeability (increased in YS) and storage capability (decreased when calsequestrin is low). Abstract Malignant hyperthermia (MH) is linked to mutations in the type 1 ryanodine receptor, RyR1, the Ca 2+ channel of the sarcoplasmic reticulum (SR) of skeletal muscle. The Y522S MH mutation was studied for its complex presentation, which includes structurally and functionally altered cell ‘cores’. Imaging cytosolic and intra‐SR [Ca 2+ ] in muscle cells of heterozygous YS mice we determined Ca 2+ release flux activated by clamp depolarization, permeability ( P ) of the SR membrane (ratio of flux and [Ca 2+ ] gradient) and SR Ca 2+ buffering power ( B ). In YS cells resting [Ca 2+ ] SR was 45% of the value in normal littermates (WT). P was more than doubled, so that initial flux was normal. Measuring [Ca 2+ ] SR ( t ) revealed dynamic changes in B ( t ). The alterations were similar to those caused by cytosolic BAPTA, which promotes release by hampering Ca 2+ ‐dependent inactivation (CDI). The [Ca 2+ ] transients showed abnormal ‘breaks’, decaying phases after an initial rise, traced to a collapse in flux and P . Similar breaks occurred in WT myofibres with calsequestrin reduced by siRNA; calsequestrin content, however, was normal in YS muscle. Thus, the Y522S mutation causes greater openness of the RyR1, lowers resting [Ca 2+ ] SR and alters SR Ca 2+ buffering in a way that copies the functional instability observed upon reduction of calsequestrin content. The similarities with the effects of BAPTA suggest that the mutation, occurring near the cytosolic vestibule of the channel, reduces CDI as one of its primary effects. The unstable SR buffering, mimicked by silencing of calsequestrin, may help precipitate the loss of Ca 2+ control that defines a fulminant MH event.
No takes yet. Share an insight, caveat, or question.
Manno et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: